Breaking

Record Violations Against Children in Conflict, UN Report Finds Indian Teenager Killed in Central Park Carriage Horse Accident FDA Advisors Unanimously Back Moderna's mRNA Flu Vaccine Taiwan Ramps Up Drone Production Amid China Tensions Judge Dismisses Rape Charge Against Former BYU Receiver Parker Kingston Duckworth Urges FAA to Resist Trump's Pressure on Triumphal Arch US Lifts Blockade on Iranian Ports as Ceasefire Agreement Takes Effect AI Inference Startup Baseten Nears $1.5 Billion Funding at $13 Billion Valuation Google's Android Developer Verification System Rolls Out This Year Apple Patches High-Severity Vulnerability in Beats Studio Buds Record Violations Against Children in Conflict, UN Report Finds Indian Teenager Killed in Central Park Carriage Horse Accident FDA Advisors Unanimously Back Moderna's mRNA Flu Vaccine Taiwan Ramps Up Drone Production Amid China Tensions Judge Dismisses Rape Charge Against Former BYU Receiver Parker Kingston Duckworth Urges FAA to Resist Trump's Pressure on Triumphal Arch US Lifts Blockade on Iranian Ports as Ceasefire Agreement Takes Effect AI Inference Startup Baseten Nears $1.5 Billion Funding at $13 Billion Valuation Google's Android Developer Verification System Rolls Out This Year Apple Patches High-Severity Vulnerability in Beats Studio Buds

拿百磷

Steady1 stories1 sourcesLast updated: 19h ago

Related Topics寶齡富錦慢性腎臟病缺鐵性貧血醫美檢測試劑童顏針

Latest Stories

寶齡富錦新藥、檢測、醫美齊推進營收添動能

Business·19h agoAI summary

寶齡富錦新藥、檢測、醫美齊推進營收添動能

寶齡富錦（1760）旗下新藥「拿百磷」適應症擴大至慢性腎臟病缺鐵性貧血，台灣藥證有望下半年取得；中國已獲准上市，並申請納入醫保。檢測領域推出三合一檢測試劑，醫美領域則有埋線產品、除斑貼片及童顏針陸續上市。